Log In
BCIQ
Print this Print this
 

BI187004, VTP-34072

  Manage Alerts
Collapse Summary General Information
Company Allergan plc
DescriptionSmall molecule hydroxysteroid 11-beta dehydrogenase 1 (HSD11B1; HSD1) inhibitor
Molecular Target Hydroxysteroid 11-beta dehydrogenase 1 (HSD11B1) (HSD1)
Mechanism of Action11beta-hydroxysteroid dehydrogenase type 1 (11b HSD1) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$639.0M

$639.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/25/2016

$639.0M

$639.0M

0

Get a free BioCentury trial today